A Revolutionary Approach to Testing

At Promus Diagnostics, we merge cutting-edge PCR technology with the foundational art of microbiology, embodying the true spirit of stewardship that our name represents. Our mission goes beyond providing results—we are committed to antimicrobial stewardship, ensuring that every test we perform supports the responsible use of antimicrobials, reducing resistance development, and preserving the effectiveness of current therapies. 

​

Understanding the challenges clinicians face daily, our in-house team of scientists and physicians continually enhances laboratory methods, refines reporting algorithms, and aligns treatment regimens to meet the unique needs of healthcare providers across specialties. By offering the most comprehensive approach to infectious disease testing, we have redefined the industry standard while upholding the principles of stewardship in healthcare.

​

Our infectious disease panels are designed to detect critical pathogens and resistance genes that impact antimicrobial therapy. With a dual approach, we offer comprehensive panels featuring extensive targets and syndromic panels tailored to your patient’s symptoms and clinical differential. This ensures precise testing while avoiding unnecessary overtesting, helping to reduce the financial burden on the healthcare system while supporting evidence-based care.

​

We’ve also transformed the potential of PCR with our proprietary reporting methods. Unlike standard PCR labs that report results in DNA copies/mL or cells/mL, we provide results in CFU/mL, units aligned with clinical guidelines (i.e., Up To Date) for direct interpretability. This innovation eliminates guesswork, prevents overtreatment, streamlines clinic workflows, and empowers clinicians to make informed, evidence-based treatment decisions.

​

At Promus Diagnostics, we are not just advancing diagnostics. We are driving smarter healthcare through innovation, stewardship, and precision.